Winthrop Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.5M Buy
17,908
+16
+0.1% +$16.3K 5.19% 2
2026
Q1
$16.5M Buy
17,892
+94
+0.5% +$95.3K 4.23% 4
2025
Q4
$19.1M Sell
17,798
-37
-0.2% -$35.4K 4.46% 3
2025
Q3
$13.6M Buy
17,835
+174
+1% +$129K 3.29% 6
2025
Q2
$13.8M Sell
17,661
-295
-2% -$229K 3.48% 4
2025
Q1
$14.8M Buy
17,956
+75
+0.4% +$62.4K 4.08% 3
2024
Q4
$13.8M Buy
+17,881
New +$14.8M 3.68% 4
2024
Q2
Sell
-17,582
Closed -$13.7M 166
2024
Q1
$13.7M Buy
+17,582
New +$12.5M 6.3% 3

Other funds holding LLY

Winthrop Capital Management's LLY Position: Q2 2026 in Review

Winthrop Capital Management increased its Eli Lilly (LLY) stake by 0.09% in Q2 2026, buying an estimated $16.3K and bringing the position to 17,908 shares worth $21.5M. The position accounts for 5.19% of the portfolio, ranked #2.

Winthrop Capital Management first reported a position in LLY in Q1 2024 and has held it in 8 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Winthrop Capital Management held 17,908 shares of Eli Lilly worth $21.5M as of Q2 2026.
  • Winthrop Capital Management bought 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
  • Eli Lilly made up 5.19% of Winthrop Capital Management's portfolio in Q2 2026, its #2 holding.
  • Winthrop Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 8 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.